Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances? 
Samsung Follows Apple, Abandons Autonomous Driving and EV Research Initiatives 
Divesting university endowments: Easier demanded than done 
JPMorgan, Susquehanna Make Bold Moves with Bitcoin ETF Investments 
SEC Opens Investigation into Boeing Co. over Safety Statements 
Aggressive? Homophobic? Stoic? Here’s what thousands of Australian men told us about modern masculinity 
What are heart rate zones, and how can you incorporate them into your exercise routine? 
Sriracha Shortage Predicted as Huy Fong Foods Stops Production of Famous Chili Sauce 
PepsiCo Aims to Make Its Spain Plant the First Facility to Reach Net-Zero Emissions 
Good for your health and the environment: why we should be eating oily fish 
Inflation is slowly falling, while student debt is climbing: 6 graphs that explain today’s CPI 
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots 
Sam Altman Denies New Search Engine; OpenAI Rumored for Voice AI Launch 
USAID and The Coca-Cola Foundation Launch Initiative to Combat Plastic Waste in Nigeria 
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
